ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MIST vs PMN // ENTERPRISE SCALE & MARKET CAP

Milestone Pharmaceuticals Inc. (NASDAQ) VS. ProMIS Neurosciences Inc. (ON) (NASDAQ) • 15-METRIC TALLY: MIST 1 — PMN 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PMN
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIST VS. PMN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MIST PMN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 1/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.0 26.6 +19.36 MIST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $98.3M $99.4M -$1.1M PMN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MIST REV PMN REV MIST GROSS % PMN GROSS % MIST FCF PMN FCF
FY 2025 $0 $0 — — -$49.3M -$28.1M
FY 2024 $0 $0 — — -$28.9M -$27.2M
FY 2023 $0 $0 — — -$46.4M -$10.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIST // BETA —
PMN // BETA —